IL18 and metabolic syndrome: High levels of IL-18 have been found in patients with metabolic syndrome [16] and have been correlated with the development of atherosclerotic plaques, plaque instability and acute cardiovascular events [17, 18], with cardiovascular risk score (PROCAM, DAD, FRS, ASCVD) [19] and can become predictive of coronary events [20].